- Local Treatment of Hand-Foot Syndrome with Uridine/Thymidine: In Vitro Appraisal on a Human Keratinocyte Cell Line HaCaT2012 | First Faculty of Medicine, Third Faculty of Medicine
- The Protective Effect of Pyrimidine Nucleosides on Human HaCaT Keratinocytes Treated with 5-FU2015 | First Faculty of Medicine, Third Faculty of Medicine
- Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study2012 | First Faculty of Medicine
- Preclinical Tests and Small Clinical Study Evaluating the Efficacy of the Therapy of 5-FU Induced Palmar-Plantar Erythrodysesthesia with 10% Uridine Ointment2012 | First Faculty of Medicine
- Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer2020 | Faculty of Medicine in Hradec Králové
- Patient treated with third-line palliative therapy with tipiracil / trifluridine2020 | Publication without faculty affiliation
- Utility design NEXCREAM no. 19655Publication without faculty affiliation
- Prototype NEXCREAM - due to utility design no. 19655Publication without faculty affiliation
- Proven technology NEXCREAM ? company standard PN OT ? 02-2009 due to utility design no. 19655Publication without faculty affiliation
- Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years2020 | Faculty of Medicine in Hradec Králové
- Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression2007 | First Faculty of Medicine
- Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial2023 | First Faculty of Medicine
- Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy2012 | Faculty of Medicine in Pilsen
- Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer2013 | First Faculty of Medicine